Table 2. Demographics for 26 patients undergoing hepatic resection after TARE.

Variable	N=26†
Age, years, mean (range)	58.3 [17–88]
Body mass index, mean (range)	26 [17–40]
Male	9 (34.6)
Liver disease	5 (19.2)
Steatosis	1 (3.8)
Fibrosis (minimal)	1 (3.8)
Cirrhosis/Mild portal hypertension	4 (15.4)
ASA
II	3 (11.5)
III	20 (76.9)
IV	3 (11.5)

^†, values reported as n (%) unless otherwise indicated. ASA, American Society of Anesthesiologists score; TARE, transarterial radioembolization.